Article Details

Felix Biotechnology announces initiation of the CYPHY Phase 1/2 study at Yale for its lead asset ...

Retrieved on: 2021-01-07 21:00:00

Tags for this article:

Click the tags to see associated articles and topics

Felix Biotechnology announces initiation of the CYPHY Phase 1/2 study at Yale for its lead asset .... View article details on hiswai:

Excerpt

SAN FRANCISCO, Jan. 7, 2021 /PRNewswire/ -- Felix Biotechnology today announced the initiation of CYPHY, a Phase 1/2 investigator-initiated ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up